In-Vitro Cytotoxicity Test (ISO 10993-5) โ Ensuring Cellular Safety in Medical Innovation
Ribosome Research Centre provides In-Vitro Cytotoxicity Test as per ISO 10993-5 using L929 Mouse Fibroblast Cell Line. This critical first step in the biological evaluation of medical devices ensures that medical devices and materials are safe for contact with human tissues and do not cause harmful effects to living cells.
Ribosome Research Centre Pvt. Ltd.
Share on LinkedIn
In-Vitro Cytotoxicity Test (ISO 10993-5) โ Ensuring Cellular Safety in Medical Innovation
Biological evaluation is the foundation of medical device safety. Before a device reaches patients, it must be proven that it does not harm living cells.
At Ribosome Research Centre Pvt. Ltd. (RRC), a Leading Global Contract Research Organization, we perform In-Vitro Cytotoxicity Testing using the L929 mouse fibroblast cell line, ensuring that medical devices and materials are safe for contact with human tissues.
Proven Expertise in Medical Device Biocompatibility
Our organization performs in-vitro cytotoxicity testing using the L929 mouse fibroblast cell line, ensuring that medical devices and materials are safe for contact with human tissues.
This test is a critical first step in the biological evaluation of medical devices, helping manufacturers demonstrate that their products do not cause harmful effects to living cells.
Why This Test is Critical
Evaluates cell damage, reduced cell viability & cell death
Rapid, sensitive, cost-effective screening method
Predicts potential biological hazards early in product development
This early screening helps manufacturers identify toxic materials before investing in expensive in-vivo studies.
Results Interpretation
Non-Cytotoxic Response
No toxic effects on mammalian cells
โ Safe for further evaluation
Cytotoxic Response
Material may release harmful substances
โ Requires investigation / modification
Our detailed report provides clear interpretation, microscopic evaluation, and regulatory-ready documentation.
Our Testing Scope
1. Implantable Devices
Examples: Orthopedic, Cardiovascular, Sutures
2. Wound & Surgical Products
Examples: Dressings, Gloves, Sutures, Wound Care
3. Diagnostic Devices
Examples: Catheters, Tubing, Blood Collection
4. Ophthalmic & ENT Devices
Examples: Contact Lenses, Ocular Inserts, Nasal Devices
5. Raw Materials
Examples: Polymers, Elastomers, Adhesives, Coatings, Textiles
Gold Standard Testing Methodology
At Ribosome Research Centre, we follow a validated, gold-standard methodology:
Standard: Full compliance with ISO 10993 & ISO 10993-12
Cell Line: L929 Mouse Fibroblast Cell Line (ISO Recommended)
Test Methods: Extract / Direct Contact / Agar Overlay
Endpoints: Cell Morphology & Viability Assessment
Controls: Certified Positive & Negative References
Quality: ISO/IEC 17025 Compliant Laboratory Conditions
This approach ensures scientific accuracy, reproducibility, and regulatory acceptance.
Why Choose Ribosome Research Centre?
ISO/IEC 17025 Compliant Lab
Experienced Biocompatibility & Cytotoxicity Experts
Compliance with ISO 10993-5 & ISO 10993-12
Validated Controls and Gold Standard Methodology
Comprehensive Technical Documentation
Timely Project Execution
Audit and Inspection Support
We focus on delivering reliable, scientifically supported testing solutions that strengthen your biocompatibility program and help maintain product safety and patient trust.
Contact Ribosome Research Centre
Looking for reliable In-Vitro Cytotoxicity Test services as per ISO 10993-5?
Connect with Ribosome Research Centre to strengthen your biocompatibility testing program.
Contact Numbers: +91 99041 55567 | +91 72111 55605
Email: ceo@ribosomeresearch.com | bd3@ribosomeresearch.com
Website: www.ribosomeresearch.com
Address: Kim Kudsad - 394110, Ta: Olpad, Surat, Gujarat, INDIA
Organization: Ribosome Research Centre Pvt. Ltd. (RRC) - Leading Global Contract Research Organization

